Synaptic degeneration in Alzheimer's disease
The DOI matches its Crossref record; 231 of the 233 references it cites were found in a registry or an index.
Abstract
Synaptic loss is the major neurobiological substrate of cognitive dysfunction in Alzheimer's disease (AD). Synaptic failure is an early event in the pathogenesis that is clearly detectable already in patients with mild cognitive impairment (MCI), a prodromal state of AD. It progresses during the course of AD and in most early stages involves mechanisms of compensation before reaching a stage of decompensated function. This dynamic process from an initially reversible functionally responsive stage of down-regulation of synaptic function to stages irreversibly associated with degeneration might be related to a disturbance of structural brain self-organization and involves morpho-regulatory molecules such as the amyloid precursor protein. Further, recent evidence suggests a role for diffusible oligomers of amyloid beta in synaptic dysfunction. To form synaptic connections and to continuously re-shape them in a process of ongoing structural adaptation, neurons must permanently withdraw from the cell cycle. Previously, we formulated the hypothesis that differentiated neurons after having withdrawn from the cell cycle are able to use molecular mechanisms primarily developed to control proliferation alternatively to control synaptic plasticity. The existence of these alternative effector pathways within neurons might put them at risk of erroneously converting signals derived from plastic synaptic changes into the program of cell cycle activation, which subsequently leads to cell death. The molecular mechanisms involved in cell cycle activation might, thus, link aberrant synaptic changes to cell death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synaptic loss is frequently cited as the best neuropathological correlate of dementia severity in AD (Terry, et al., 1991) and has been linked to the accumulation of both amyloid-β and tau pathology (Arendt, 2009).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Arendt, 2009
In the citing paper
“Detailed analysis of postmortem tissue has revealed synapse loss in mild cognitive impairment (MCI), but an even greater loss in Alzheimer’s disease, indicating that synapse loss occurs early in the progression of Alzheimer’s disease and worsens as the disease advances21.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [21]
In the citing paper
“Individuals with Alzheimer’s disease demonstrate altered expression of many synaptic proteins21.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [21]
In the citing paper
“Synapses have long been viewed as critical sites of AD pathology [6, 28, 112, 119, 168] and diverse evidence had supported that synapses are major sites of Aβ pathology and also generation.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [6]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“fibrillary degeneration as outlined in the Braaks’ staging [24].”
BackgroundSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“There is evidence that soluble oligomers of Ab can selectively impair synaptic plasticity mechanisms necessary for memory processing [35, 71, 176].”
BackgroundGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“It had not been analyzed previously, however, whether this synaptotrophic effect is maintained in mutated forms of APP that show linkage to familial forms of AD (FAD) and thus have been identified as one potential cause of the disease [64].”
BackgroundAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · cited 1×
“extensively, and numerous studies have focused on elevations in the Ab-peptide, which is generated during normal metabolism of APP [70] and forms the major component of plaques, a major hallmark of the disease [142].”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 4×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundResultInfluentialWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundDegeneration and Regeneration of the Nervous System.
(1929) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1929.02710220063037 · Cited by 2,908
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 2×
“Dynamic synaptic reorganization during the process of degeneration is further supported by observations of an increase in synaptic size that accompanies synaptic loss in various cortical regions in AD and might reflect the attempt of a functional compensatory increase of synaptic efficacy [18, 44, 182].”
BackgroundPerry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042 · cited 1×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundNeurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · cited 1×
“Other studies, however, have suggested opposite effects with picomolar levels of Ab1-40 playing a neurotrophic role in cell cultures [161, 231].”
ResultAmyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“extensively, and numerous studies have focused on elevations in the Ab-peptide, which is generated during normal metabolism of APP [70] and forms the major component of plaques, a major hallmark of the disease [142].”
BackgroundMucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 2×
“Studies on overexpression or knockout of APP and its homologues indicate a critical role in neuronal survival, neurite outgrowth, synaptogenesis and synaptic plasticity [41, 115, 148, 152, 191].”
BackgroundMethodAmyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611 · cited 1×
“APP is a type I transmembrane protein that belongs to a conserved family including Apl-1 in Caenorhabditis elegans [37], APPL in Drosophila [129, 173] and APP [209], APP-like protein 1 (APLP1) [226] and APLP2 [197, 227] in mammals.”
BackgroundDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 1×
“and neurofibrillary tangles [4, 5, 223].”
Plasticity in the human central nervous system
Cooke, S. F. (2006) · Brain · doi:10.1093/brain/awl082 · Cited by 1,200 · cited 1×
“There is evidence that soluble oligomers of Ab can selectively impair synaptic plasticity mechanisms necessary for memory processing [35, 71, 176].”
BackgroundNetwork Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease
Supekar, K., Menon, V., Rubin, D., Musen, M., & Greicius, M. D. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000100 · Cited by 1,148 · cited 1×
“In AD patients, cognitive decline is associated with disrupted functional connectivity in the entire brain [204].”
BackgroundSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundSelective changes of resting-state networks in individuals at risk for Alzheimer’s disease
Sorg, C., Riedl, V., Mühlau, M., Calhoun, V. D., Eichele, T., Läer, L., Drzezga, A., Förstl, H., Kurz, A., Zimmer, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708803104 · Cited by 1,036 · cited 1×
“AD patients have significantly lower regional connectivity and show disrupted global functional brain network organization when compared to healthy controls [199, 224].”
BackgroundHippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“Disturbances of synaptic integrity can be detected already in patients with mild cognitive impairment (MCI), a prodromal state of AD [133, 184], suggesting that synaptic degeneration occurs very early on in the process of AD.”
BackgroundImpaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946 · cited 2×
“Synaptotrophic function of human wild-type APP and its failure in FAD-mutated APP Disturbances of synaptic function and plasticity have also been observed in transgenic mice overexpressing FAD- mutated APP [32, 54, 62, 65].”
BackgroundWang, L., Zang, Y., He, Y., Liang, M., Zhang, X., Tian, L., Wu, T., Jiang, T., & Li, K. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.12.033 · Cited by 854 · cited 1×
“AD patients have significantly lower regional connectivity and show disrupted global functional brain network organization when compared to healthy controls [199, 224].”
BackgroundKoffie, R. M., Meyer-Luehmann, M., Hashimoto, T., Adams, K. W., Mielke, M. L., Garcia-Alloza, M., Micheva, K. D., Smith, S. J., Kim, M. L., Lee, V. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811698106 · Cited by 850 · cited 1×
“Still, a recent study applying array tomography, a technique that combines ultrathin sectioning of tissue with immunofluorescence, to a mouse model of AD provides compelling evidence that senile plaques are a potential reservoir of synaptotoxic oligomeric Ab [100].”
BackgroundSynaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824 · cited 2×
“Synaptic loss might even be more pronounced in the hippocampus where it amounts to 44% to 55% [183].”
BackgroundNormal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Katzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 1×
“Also, low picomolar concentrations of preparations containing both Ab1-42 monomers and oligomers have been shown to be able to induce a marked increase in hippocampal long-term potentiation and produce a pronounced enhancement of both reference and contextual fear memory [164].”
BackgroundPrecursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733 · cited 1×
“APP undergoes fast axonal transport [101, 178, 229] and is targeted to synaptic sites [187, 193].”
BackgroundAltered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720 · cited 2×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
BackgroundResultβ-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
Zheng, H., Jiang, M., Trumbauer, M. E., Sirinathsinghji, D. J. S., Hopkins, R., Smith, D. W., Heavens, R. P., Dawson, G. R., Boyce, S., Conner, M. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90073-x · Cited by 704
Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I., & Rydel, R. E. (1993) · Neuron · doi:10.1016/0896-6273(93)90315-i · Cited by 656
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628 · cited 1×
“35% decrease in the numerical density of synapses and a 15% to 35% loss in the number of synapses per neuron [40].”
BackgroundLewis, D., Campbell, M., Terry, R., & Morrison, J. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-06-01799.1987 · Cited by 578 · cited 1×
“Although degeneration of subcortical input might contribute to cortical synapse loss [7], most of the synaptic loss in the neocortex might derive from loss of cortico-cortical associational fibers [86, 110, 136, 137, 150].”
Backgroundβ-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease
Fukumoto, H. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1381 · Cited by 575
SZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562 · cited 4×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
ResultInfluentialThe Croonian lecture.—La fine structure des centres nerveux
Ramon y Cajal, S. (1894) · Proceedings of the Royal Society of London · doi:10.1098/rspl.1894.0063 · Cited by 502
Heber, S., Herms, J., Gajic, V., Hainfellner, J., Aguzzi, A., Rülicke, T., Kretzschmar, H., von Koch, C., Sisodia, S., Tremml, P., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-07951.2000 · Cited by 494 · cited 1×
“Several genetic knockout models for APP and its homologues have been generated to gain insight into its function [78, 219, 237].”
BackgroundSimpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490 · cited 1×
“From all cortical areas analyzed, the hippocampus appears to be the most severely affected by the loss of synaptic proteins, while the occipital cortex is affected least [22, 25, 26, 33, 38, 39, 56, 59, 79–81, 83, 106, 113, 117, 135, 139, 140, 157, 196, 206, 207, 211].”
BackgroundAmyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1234 · Cited by 489 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundDeficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
Dendritic Growth in the Aged Human Brain and Failure of Growth in Senile Dementia
Buell, S. J., & Coleman, P. D. (1979) · Science · doi:10.1126/science.493989 · Cited by 471 · cited 1×
“Synaptic compensatory mechanisms that in normal aging [15, 19, 20, 28, 55] succeed in preserving considerable cognitive”
BackgroundMilward, E. A., Papadopoulos, R., Fuller, S. J., Moir, R. D., Small, D., Beyreuther, K., & Masters, C. L. (1992) · Neuron · doi:10.1016/0896-6273(92)90228-6 · Cited by 458 · cited 1×
“Studies on overexpression or knockout of APP and its homologues indicate a critical role in neuronal survival, neurite outgrowth, synaptogenesis and synaptic plasticity [41, 115, 148, 152, 191].”
BackgroundQuantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446 · cited 1×
“Dynamic synaptic reorganization during the process of degeneration is further supported by observations of an increase in synaptic size that accompanies synaptic loss in various cortical regions in AD and might reflect the attempt of a functional compensatory increase of synaptic efficacy [18, 44, 182].”
BackgroundSynaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Gunawardena, S., & Goldstein, L. S. B. (2001) · Neuron · doi:10.1016/s0896-6273(01)00496-2 · Cited by 428 · cited 1×
“Studies on the Drosophila APP homologue APPL support a potential role in axonal arborization, axonal transport and synapse formation both during development and in the mature nervous system [69, 111, 122, 214].”
BackgroundFurukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051882.x · Cited by 414
Arendt, T., Bigl, V., Tennstedt, A., & Arendt, A. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90160-5 · Cited by 410 · cited 1×
“Although degeneration of subcortical input might contribute to cortical synapse loss [7], most of the synaptic loss in the neocortex might derive from loss of cortico-cortical associational fibers [86, 110, 136, 137, 150].”
BackgroundSelf-citationCorrelations of synaptic and pathological markers with cognition of the elderly
Dickson, D. W., Crystal, H. A., Bevona, C., Honer, W., Vincent, I., & Davies, P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00013-5 · Cited by 410 · cited 1×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundQuantitative synaptic alterations in the human neocortex during normal aging
Masliah, E., Mallory, M., Hansen, L., DeTeresa, R., & Terry, R. D. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.192 · Cited by 408 · cited 1×
“Although degeneration of subcortical input might contribute to cortical synapse loss [7], most of the synaptic loss in the neocortex might derive from loss of cortico-cortical associational fibers [86, 110, 136, 137, 150].”
BackgroundStructural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405
Neurodegeneration in the Central Nervous System of apoE-Deficient Mice
Masliah, E., Mallory, M., Ge, N., Alford, M., Veinbergs, I., & Roses, A. D. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1088 · Cited by 402 · cited 1×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundWasco, W., Bupp, K., Magendantz, M., Gusella, J. F., Tanzi, R. E., & Solomon, F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10758 · Cited by 399 · cited 2×
“APP is a type I transmem- brane protein that belongs to a conserved family including Apl-1 in Caenorhabditis elegans [37], APPL in Drosophila [129, 173] and APP [209], APP-like protein 1 (APLP1) [226] and APLP2 [197, 227] in mammals.”
BackgroundMind and body; The theories of their relation.
Bain, A. (1877) · D. Appleton and company eBooks · doi:10.1037/12850-000 · Cited by 392
Wasco, W., Gurubhagavatula, S., Paradis, M. D., Romano, D. M., Sisodia, S. S., Hyman, B. T., Neve, R. L., & Tanzi, R. E. (1993) · Nature Genetics · doi:10.1038/ng0993-95 · Cited by 392
Mitotic mechanisms in Alzheimer's disease?
Vincent, I., Rosado, M., & Davies, P. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.3.413 · Cited by 386 · cited 2×
“As the ras-MAP-kinase pathway also mediates mitogenic effects eventually resulting in activation of the cell cycle (see below), a scenario can be envisaged where a disturbed synaptotrophic action of APP triggers an aberrant activation of intracellular signaling cascades that eventually induce cell cycle activation and…”
BackgroundDifferential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
Reddy, P. H., Mani, G., Park, B. S., Jacques, J., Murdoch, G., Whetsell, W., Kaye, J., & Manczak, M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7203 · Cited by 372 · cited 1×
“Synaptic pathology in AD is reflected by a loss of all major components of small synaptic vesicles that accommodate classical neurotransmitters and large dense core vesicles that store most peptides, together with a loss of molecular components of pre- and postsynaptic compartments accompanied by extensive pathologica…”
BackgroundSynaptic and neuritic alterations during the progression of Alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370 · cited 1×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundDawson, G. R., Seabrook, G. R., Zheng, H., Smith, D. W., Graham, S., O'Dowd, G., Bowery, B. J., Boyce, S., Trumbauer, M. E., Chen, H. Y., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00410-2 · Cited by 366 · cited 2×
“Studies on overexpression or knockout of APP and its homologues indicate a critical role in neuronal survival, neurite outgrowth, synaptogenesis and synaptic plasticity [41, 115, 148, 152, 191].”
BackgroundImmunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease
Masliah, E., Terry, R. D., DeTeresa, R. M., & Hansen, L. A. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90582-x · Cited by 363 · cited 3×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundMeziane, H., Dodart, J.-C., Mathis, C., Little, S., Clemens, J., Paul, S. M., & Ungerer, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12683 · Cited by 357
Arendt, T., Stieler, J., Strijkstra, A. M., Hut, R. A., Rüdiger, J., Van der Zee, E. A., Harkany, T., Holzer, M., & Härtig, W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-06972.2003 · Cited by 357
Self-citationSynaptic slaughter in Alzheimer's disease
Coleman, P. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.001 · Cited by 351 · cited 2×
“ther, synaptic function is impaired in living neurons as demonstrated by decrements in transcripts related to synaptic vesicle trafficking [34].”
BackgroundSlunt, H. H., Thinakaran, G., Von Koch, C., Lo, A. C., Tanzi, R. E., & Sisodia, S. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41992-2 · Cited by 348 · cited 3×
“In agreement with previous reports on reduced syn- aptic vesicle number in APP/APLP2 knockout mice [225, 230], we further observed increased density of synaptic vesicles in mice overexpressing wild-type hAPP.”
BackgroundLipid rafts, cholesterol, and the brain
Korade, Z., & Kenworthy, A. K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.019 · Cited by 342 · cited 1×
“This assumption is further supported by alterations in the composition [20, 67, 102, 126, 205] and fluidity of membranes [53, 238] as well as by direct morphological evidence of a disturbed axonal and dendritic remodeling (for review, see [4, 5]).”
ResultHerms, J., Anliker, B., Heber, S., Ring, S., Fuhrmann, M., Kretzschmar, H., Sisodia, S., & Müller, U. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600390 · Cited by 338 · cited 1×
“Triple knockouts for APP and its homologues are lethal and show cortical dysplasia [82].”
BackgroundGeneration of APLP2 KO Mice and Early Postnatal Lethality in APLP2/APP Double KO Mice
von Koch, C. S., Zheng, H., Chen, H., Trumbauer, M., Thinakaran, G., van der Ploeg, L. H. T., Price, D. L., & Sisodia, S. S. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00151-6 · Cited by 337 · cited 1×
“Several genetic knockout models for APP and its homologues have been generated to gain insight into its function [78, 219, 237].”
BackgroundNormal aging: regionally specific changes in hippocampal synaptic transmission
Barnes, C. A. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90029-9 · Cited by 332 · cited 1×
“Synaptic compensatory mechanisms that in normal aging [15, 19, 20, 28, 55] succeed in preserving considerable cognitive”
BackgroundSvennerholm, L., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 330 · cited 1×
“This assumption is further supported by alterations in the composition [20, 67, 102, 126, 205] and fluidity of membranes [53, 238] as well as by direct morphological evidence of a disturbed axonal and dendritic remodeling (for review, see [4, 5]).”
ResultCortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.
Masliah, E., Terry, R. D., Alford, M. F., DeTeresa, R. M., & Hansen, L. A. (1991) · PubMed · Cited by 328
Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299
The Pathogenesis of Alzheimer Disease: An Alternative to the Amyloid Hypothesis
Terry, R. D. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199610000-00001 · Cited by 299
Wang, P., Yang, G., Mosier, D. R., Chang, P., Zaidi, T., Gong, Y.-D., Zhao, N.-M., Dominguez, B., Lee, K.-F., Gan, W.-B., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4660-04.2005 · Cited by 290
Secreted Forms of β‐Amyloid Precursor Protein Protect Against Ischemic Brain Injury
Smith‐Swintosky, V. L., Pettigrew, L. C., Craddock, S. D., Culwell, A. R., Rydel, R. E., & Mattson, M. P. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020781.x · Cited by 283 · cited 1×
“Studies on APP fragment function have demonstrated that both sAPPalpha and the APP intracellular domain may have neurotrophic properties and enhance synaptic plasticity and memory [2, 57, 91, 111, 123, 143–145, 151, 171, 198, 213].”
BackgroundSynaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice
Mucke, L., Masliah, E., Johnson, W. B., Ruppe, M. D., Alford, M., Rockenstein, E. M., Forss-Petter, S., Pietropaolo, M., Mallory, M., & Abraham, C. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90767-6 · Cited by 271 · cited 1×
“Evidence for synaptotrophic effects of APP were, in addition, obtained by a variety of transgenic approaches generating different lines of mice overexpressing different hAPP isoforms under control of different promotors [131, 151, 171, 214].”
BackgroundTorroja, L., Packard, M., Gorczyca, M., White, K., & Budnik, V. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07793.1999 · Cited by 268 · cited 2×
“Evidence for synaptotrophic effects of APP were, in addition, obtained by a variety of transgenic approaches generating different lines of mice overexpressing different hAPP isoforms under control of different promotors [131, 151, 171, 214].”
BackgroundThe Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons
Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 266 · cited 1×
“Other studies, however, have suggested opposite effects with picomolar levels of Ab1-40 playing a neurotrophic role in cell cultures [161, 231].”
ResultLocalization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites
Schubert, W., Prior, R., Weidemann, A., Dircksen, H., Multhaup, G., Masters, C. L., & Beyreuther, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91532-6 · Cited by 265 · cited 2×
“APP undergoes fast axonal transport [101, 178, 229] and is targeted to synaptic sites [187, 193].”
BackgroundSeabrook, G. R., Smith, D. W., Bowery, B. J., Easter, A., Reynolds, T., Fitzjohn, S. M., Morton, R. A., Zheng, H., Dawson, G. R., Sirinathsinghji, D. J. S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00204-4 · Cited by 256 · cited 1×
“Mice deficient in APP show abnormalities in expression of synaptic markers and in axonal and dendritic arborization, together with neurological and behavioral dysfunction and impaired long-term potentiation [41, 124, 159, 188, 237].”
BackgroundRoch, J. M., Masliah, E., Roch-Levecq, A. C., Sundsmo, M. P., Otero, D. A., Veinbergs, I., & Saitoh, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7450 · Cited by 255 · cited 1×
“Evidence for synaptotrophic effects of APP were, in addition, obtained by a variety of transgenic approaches generating different lines of mice overexpressing different hAPP isoforms under control of different promotors [131, 151, 171, 214].”
BackgroundExpression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease
Lars Rödel, T. A., Gärtner, U., & Holzer, M. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00050 · Cited by 250 · cited 2×
“As the ras-MAP-kinase pathway also mediates mitogenic effects eventually resulting in activation of the cell cycle (see below), a scenario can be envisaged where a disturbed synaptotrophic action of APP triggers an aberrant activation of intracellular signaling cascades that eventually induce cell cycle activation and…”
BackgroundLue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246 · cited 2×
“While a few studies [106, 180, 207] described a link between higher plaques counts and lower synaptic protein measures, other studies failed to establish such a relationship [79, 80, 83, 117, 141].”
BackgroundResultSPERLING, R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.009 · Cited by 245 · cited 1×
“Functional magnetic resonance imaging (fMRI) on MCI patients similarly suggests that there might be a phase of paradoxically increased activation early in the course of prodromal AD [200].”
BackgroundAmyloid precursor protein promotes post‐developmental neurite arborization in the Drosophila brain
Leyssen, M., Ayaz, D., Hébert, S. S., Reeve, S., De Strooper, B., & Hassan, B. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600757 · Cited by 245 · cited 3×
“Intracerebral administration of sAPP sig- nificantly increases synaptogenesis, reduces neuronal injury and improves functional motor outcome following brain injury in rats [17, 213], an effect that likely depends on a conserved motif in the C-terminus [111].”
BackgroundPopov, V. I., Bocharova, L. S., & Bragin, A. G. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90336-z · Cited by 241 · cited 2×
“Furthermore, the stage of torpor in hibernating animals shows significant analogies to the pathophysiological condition of AD with respect to an altered synaptic connectivity [11, 125, 162, 163, 203, 218] and the impairment of cognitive function [147, 201].”
BackgroundJohnson, S. C., Schmitz, T. W., Moritz, C. H., Meyerand, M. E., Rowley, H. A., Alexander, A. L., Hansen, K. W., Gleason, C. E., Carlsson, C. M., Ries, M. L., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.017 · Cited by 234 · cited 1×
“Reduced functional connectivity of the hippocampus can already be obtained in MCI patients compared to normal aging control subjects [13, 92].”
BackgroundNagy, Z., Esiri, M. M., & Smith, A. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050617 · Cited by 227 · cited 2×
“As the ras-MAP-kinase pathway also mediates mitogenic effects eventually resulting in activation of the cell cycle (see below), a scenario can be envisaged where a disturbed synaptotrophic action of APP triggers an aberrant activation of intracellular signaling cascades that eventually induce cell cycle activation and…”
BackgroundDeKosky, D. S. T., Harbaugh, R. E., Schmitt, F. A., Bakay, R. A. E., Chui, H. C., Knopman, D. S., Reeder, T. M., Shetter, A. G., Senter, H. J., Markesbery, W. R., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320505 · Cited by 224 · cited 1×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundDaigle, I., & Li, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12045 · Cited by 222 · cited 1×
“APP is a type I transmembrane protein that belongs to a conserved family including Apl-1 in Caenorhabditis elegans [37], APPL in Drosophila [129, 173] and APP [209], APP-like protein 1 (APLP1) [226] and APLP2 [197, 227] in mammals.”
BackgroundCounts, S. E., Nadeem, M., Lad, S. P., Wuu, J., & Mufson, E. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00007 · Cited by 215 · cited 1×
“Other studies indicated an increase in drebrin in the frontal cortex of patients with MCI followed by a 40% to 60% decrease in severe AD [36], an increase in the expression of postsynaptic density protein PSD-95 in AD brain [109], as well as an elevation in glutamatergic presynaptic bouton density in midfrontal gyrus…”
BackgroundA Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor.
Rosen, D. R., Martin-Morris, L., Luo, L. Q., & White, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2478 · Cited by 215 · cited 5×
“APP is a type I transmem- brane protein that belongs to a conserved family including Apl-1 in Caenorhabditis elegans [37], APPL in Drosophila [129, 173] and APP [209], APP-like protein 1 (APLP1) [226] and APLP2 [197, 227] in mammals.”
BackgroundInfluentialTrophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture
Araki, W., Kitaguchi, N., Tokushima, Y., Ishii, K., Aratake, H., Shimohama, S., Nakamura, S., & Kimura, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81412-3 · Cited by 213
Diffuse plaques do not accentuate synapse loss in Alzheimer's disease.
(1990) · Europe PMC (PubMed Central) · Cited by 209
Yamazaki, T., Selkoe, D. J., & Koo, E. H. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.2.431 · Cited by 208 · cited 1×
“APP undergoes fast axonal transport [101, 178, 229] and is targeted to synaptic sites [187, 193].”
BackgroundYao, P. J., Zhu, M., Pyun, E. I., Brooks, A. I., Therianos, S., Meyers, V. E., & Coleman, P. D. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00009-8 · Cited by 206 · cited 1×
“Synaptic pathology in AD is reflected by a loss of all major components of small synaptic vesicles that accommodate classical neurotransmitters and large dense core vesicles that store most peptides, together with a loss of molecular components of pre- and postsynaptic compartments accompanied by extensive pathologica…”
BackgroundBlennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., & Davidsson, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01273157 · Cited by 206 · cited 3×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
ResultPopov, V. I., & Bocharova, L. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90337-2 · Cited by 203
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundHatanpää, K., Isaacs, K. R., Shirao, T., Brady, D. R., & Rapoport, S. I. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00008 · Cited by 200 · cited 2×
“Neurogranin, drebrin E and A [31, 38, 75, 77] Acta Neuropathol (2009) 118:167–179 169”
BackgroundResultDisappearance of actin‐binding protein, drebrin, from hippocampal synapses in alzheimer's disease
Harigaya, Y., Shoji, M., Shirao, T., & Hirai, S. (1996) · Journal of Neuroscience Research · doi:10.1002/jnr.490430111 · Cited by 198 · cited 1×
“Neurogranin, drebrin E and A [31, 38, 75, 77] Acta Neuropathol (2009) 118:167–179 169”
BackgroundRoßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 198
Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 191
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 188 · cited 5×
“These data directly support our hypothesis that neurons have evolutionarily acquired the ability to use molecular mechanisms primarily developed to control proliferation alternatively to control synaptic plasticity [5].”
BackgroundResultInfluentialSelf-citationSabo, S. L., Ikin, A. F., Buxbaum, J. D., & Greengard, P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05407.2003 · Cited by 187 · cited 1×
“APP undergoes fast axonal transport [101, 178, 229] and is targeted to synaptic sites [187, 193].”
BackgroundMukaetova-Ladinska, E. B., Garcia-Siera, F., Hurt, J., Gertz, H. J., Xuereb, J. H., Hills, R., Brayne, C., Huppert, F. A., Paykel, E. S., McGee, M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64573-7 · Cited by 187 · cited 1×
“, prior to neurofibrillary pathology [153].”
Gonatas, N. K., Anderson, W., & Evangelista, I. (1967) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196701000-00003 · Cited by 186 · cited 1×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundHeinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Palja¨rvi, L., Koivisto, E., & Riekkinen, P. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00422-2 · Cited by 186 · cited 3×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundBai, F., Zhang, Z., Watson, D. R., Yu, H., Shi, Y., Yuan, Y., Zang, Y., Zhu, C., & Qian, Y. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.017 · Cited by 186 · cited 1×
“Reduced functional connectivity of the hippocampus can already be obtained in MCI patients compared to normal aging control subjects [13, 92].”
BackgroundMasliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., Deteresa, R., & Terry, R. D. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199207000-00003 · Cited by 183 · cited 2×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
BackgroundResultNeurochemical Dissection of Synaptic Pathology in Alzheimer's Disease
Davidsson, P., & Blennow, K. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005110 · Cited by 182 · cited 3×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
BackgroundIntercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease
Horwitz, B., Grady, C. L., Schlageter, N. L., Duara, R., & Rapoport, S. I. (1987) · Brain Research · doi:10.1016/0006-8993(87)91107-3 · Cited by 181 · cited 1×
“Although degeneration of subcortical input might contribute to cortical synapse loss [7], most of the synaptic loss in the neocortex might derive from loss of cortico-cortical associational fibers [86, 110, 136, 137, 150].”
BackgroundRegional synaptic pathology in Alzheimer's disease
Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90111-a · Cited by 179 · cited 5×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundResultInfluentialIshida, A., Furukawa, K., Keller, J. N., & Mattson, M. P. (1997) · NeuroReport · doi:10.1097/00001756-199707070-00009 · Cited by 178
Thornton, E., Vink, R., Blumbergs, P. C., & Van Den Heuvel, C. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.107 · Cited by 172
Magara, F., Müller, U., Li, Z.-W., Lipp, H.-P., Weissmann, C., Stagljar, M., & Wolfer, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4656 · Cited by 170 · cited 1×
“Mice deficient in APP show abnormalities in expression of synaptic markers and in axonal and dendritic arborization, together with neurological and behavioral dysfunction and impaired long-term potentiation [41, 124, 159, 188, 237].”
BackgroundAlzheimer's disease as a disorder of mechanisms underlying structural brain self-organization
Arendt, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00516-9 · Cited by 169
Self-citationFitzjohn, S. M., Morton, R. A., Kuenzi, F., Rosahl, T. W., Shearman, M., Lewis, H., Smith, D., Reynolds, D. S., Davies, C. H., Collingridge, G. L., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04691.2001 · Cited by 168 · cited 2×
“Synaptotrophic function of human wild-type APP and its failure in FAD-mutated APP Disturbances of synaptic function and plasticity have also been observed in transgenic mice overexpressing FAD- mutated APP [32, 54, 62, 65].”
BackgroundSAMUEL, W., ALFORD, M., HOFSTETTER, C. R., & HANSEN, L. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199705000-00006 · Cited by 167 · cited 3×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
BackgroundResult(1995) · PubMed · Cited by 167
Muntané, G., Dalfó, E., Martínez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 165
Degeneration and Regeneration of the Nervous System
G., J. G. (1929) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-9.36.378 · Cited by 164
Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains
Sze, C.-I., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00285-9 · Cited by 161
Lassmann, H., Weiler, R., Fischer, P., Bancher, C., Jellinger, K., Floor, E., Danielczyk, W., Seitelberger, F., & Winkler, H. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90003-k · Cited by 160 · cited 5×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
BackgroundResultInfluentialNeurotrophins, synaptic plasticity and dementia
Arancio, O., & Chao, M. V. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.013 · Cited by 156 · cited 1×
“Recent evidence suggests that APP and neurotrophic factors such as NGF and BDNF use similar intracellular pathways to control neuronal plasticity [3].”
BackgroundMattson, M. P. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250409 · Cited by 154
Liu, X., Erikson, C., & Brun, A. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106867 · Cited by 152 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction
Rowan, M. J., Klyubin, I., Wang, Q., Hu, N. W., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 152 · cited 1×
“There is evidence that soluble oligomers of Ab can selectively impair synaptic plasticity mechanisms necessary for memory processing [35, 71, 176].”
BackgroundAlzheimer's disease: Advances in clinical and basic research
Absher, J. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90166-x · Cited by 152
Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
Takahashi, R. H., Capetillo-Zarate, E., Lin, M. T., Milner, T. A., & Gouras, G. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.021 · Cited by 150 · cited 1×
“A direct link between hyperphosphorylated tau and synaptic pathology is also supported by recent reports on an accumulation of abnormally phosphorylated tau species within synaptic terminals in AD brains and APP Swedish mutant transgenic mice [154, 208].”
Resultβ‐Amyloid Precursor Protein Isoforms in Various Rat Brain Regions and During Brain Development
Löffler, J., & Huber, G. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08443.x · Cited by 150
Luo, L., Martin-Morris, L., & White, K. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-12-03849.1990 · Cited by 146 · cited 1×
“Studies on the Drosophila APP homologue APPL support a potential role in axonal arborization, axonal transport and synapse formation both during development and in the mature nervous system [69, 111, 122, 214].”
BackgroundMagariños, A. M., McEwen, B. S., Saboureau, M., & Pevet, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608785103 · Cited by 145 · cited 1×
“Furthermore, the stage of torpor in hibernating animals shows significant analogies to the pathophysiological condition of AD with respect to an altered synaptic connectivity [11, 125, 162, 163, 203, 218] and the impairment of cognitive function [147, 201].”
BackgroundParadoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment
Bell, K. F. S., Bennett, D. A., & Cuello, A. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3269-07.2007 · Cited by 142 · cited 1×
“Other studies indicated an increase in drebrin in the frontal cortex of patients with MCI followed by a 40% to 60% decrease in severe AD [36], an increase in the expression of postsynaptic density protein PSD-95 in AD brain [109], as well as an elevation in glutamatergic presynaptic bouton density in midfrontal gyrus…”
BackgroundThe Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System
Masliah, E., & Terry, R. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00728.x · Cited by 141 · cited 1×
“Although degeneration of subcortical input might contribute to cortical synapse loss [7], most of the synaptic loss in the neocortex might derive from loss of cortico-cortical associational fibers [86, 110, 136, 137, 150].”
BackgroundClinical Correlates of Cortical and Nucleus Basalis Pathology in Alzheimer Dementia
Samuel, W., Terry, R. D., DeTeresa, R., Butters, N., & Masliah, E. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540200048015 · Cited by 141 · cited 3×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
ResultLübec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N. J., & Fountoulakis, M. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_10 · Cited by 137 · cited 1×
“Findings of a deregulation of proteins involved in structural plasticity of axons and dendrites [1, 51, 77, 93, 116, 146] as well as results of computational studies [76, 85] indicate a failure of local neuronal regulatory mechanisms of synaptic plasticity and make a primary disturbance of synapse turnover very likely.”
ResultAlzheimer's disease and aging: Effects on perforant pathway perikarya and synapses
Lippa, C. F., Hamos, J. E., Pulaski-Salo, D., DeGennaro, L. J., & Drachman, D. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90115-e · Cited by 135 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals
Honer, W. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.005 · Cited by 135 · cited 1×
“Synaptic pathology in AD is reflected by a loss of all major components of small synaptic vesicles that accommodate classical neurotransmitters and large dense core vesicles that store most peptides, together with a loss of molecular components of pre- and postsynaptic compartments accompanied by extensive pathologica…”
BackgroundPhinney, A. L., Calhoun, M. E., Wolfer, D. P., Lipp, H., Zheng, H., & Jucker, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00645-9 · Cited by 134 · cited 1×
“Mice deficient in APP show abnormalities in expression of synaptic markers and in axonal and dendritic arborization, together with neurological and behavioral dysfunction and impaired long-term potentiation [41, 124, 159, 188, 237].”
BackgroundBoynton, S., & Tully, T. (1992) · Genetics · doi:10.1093/genetics/131.3.655 · Cited by 133
Zubenko, G. S., Kopp, U., Seto, T., & Firestone, L. L. (1999) · Psychopharmacology · doi:10.1007/s002130051046 · Cited by 133
Bertoni–Freddari, C., Fattoretti, P., Casoli, T., Meier-Ruge, W. A., & ULRICH, J. (1990) · Brain Research · doi:10.1016/0006-8993(90)91009-6 · Cited by 132 · cited 1×
“Dynamic synaptic reorganization during the process of degeneration is further supported by observations of an increase in synaptic size that accompanies synaptic loss in various cortical regions in AD and might reflect the attempt of a functional compensatory increase of synaptic efficacy [18, 44, 182].”
BackgroundCallahan, L. M., Vaules, W. A., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199903000-00007 · Cited by 129 · cited 3×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
BackgroundArendt, T., Holzer, M., Grossmann, A., Zedlick, D., & Brückner, M. K. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00146-a · Cited by 129 · cited 2×
“This cell-cycle re-activation most likely is a down-stream effect of aberrantly activated mitogenic signalling pathways [10, 60, 61].”
BackgroundSelf-citationADAM-10 over-expression increases cortical synaptogenesis
Bell, K. F. S., Zheng, L., Fahrenholz, F., & Cuello, A. C. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.004 · Cited by 129 · cited 1×
“Intracerebral administration of sAPP significantly increases synaptogenesis, reduces neuronal injury and improves functional motor outcome following brain injury in rats [17, 213], an effect that likely depends on a conserved motif in the C-terminus [111].”
BackgroundMemory, sleep and the evolution of mechanisms of synaptic efficacy maintenance
Kavanau, J. L. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00610-0 · Cited by 128 · cited 1×
“As activity is a measure of use, and neuronal connections remain functional through regular use, this decrease negatively affects the maintenance of neuronal connections [96].”
BackgroundGabriel, S. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180077010 · Cited by 126 · cited 3×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundMa, H., Lesné, S., Kotilinek, L., Steidl-Nichols, J. V., Sherman, M., Younkin, L., Younkin, S., Forster, C., Sergeant, N., Delacourte, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609521104 · Cited by 120 · cited 1×
“This effect correlates with elevated levels of the APP intracellular domain, which has been implicated in the regulation of gene transcription and calcium signaling [123].”
BackgroundSynaptic Protein Dynamics in Hibernation
von der Ohe, C. G., Garner, C. C., Darian-Smith, C., & Heller, H. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4385-06.2007 · Cited by 120 · cited 1×
“Furthermore, the stage of torpor in hibernating animals shows significant analogies to the pathophysiological condition of AD with respect to an altered synaptic connectivity [11, 125, 162, 163, 203, 218] and the impairment of cognitive function [147, 201].”
BackgroundHibernation Effects on Memory in European Ground Squirrels (Spermophilus citellus)
Millesi, E., Prossinger, H., Dittami, J. P., & Fieder, M. (2001) · Journal of Biological Rhythms · doi:10.1177/074873001129001971 · Cited by 117 · cited 1×
“Furthermore, the stage of torpor in hibernating animals shows significant analogies to the pathophysiological condition of AD with respect to an altered synaptic connectivity [11, 125, 162, 163, 203, 218] and the impairment of cognitive function [147, 201].”
BackgroundGötz, J., Ittner, L. M., & Kins, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03955.x · Cited by 116 · cited 2×
“Synaptotrophic function of human wild-type APP and its failure in FAD-mutated APP Disturbances of synaptic function and plasticity have also been observed in transgenic mice overexpressing FAD- mutated APP [32, 54, 62, 65].”
BackgroundPinto, S., Quintana, D. G., Smith, P., Mihalek, R., Hou, Z.-H., Boynton, S., Jones, C. J., Hendricks, M., Velinzon, K., Wohlschlegel, J. A., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80752-7 · Cited by 116
Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo
Klyubin, I., Walsh, D. M., Cullen, W. K., Fadeeva, J. V., Anwyl, R., Selkoe, D. J., & Rowan, M. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03389.x · Cited by 115 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundZhan, S.-S., Beyreuther, K., & Schmitt, H. P. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107299 · Cited by 110 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Yang, G., Gong, Y.-D., Gong, K., Jiang, W.-L., Kwon, E., Wang, P., Zheng, H., Zhang, X.-F., Gan, W., & Zhao, N.-M. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.040 · Cited by 110
Mikkonen, M., Soininen, H., Tapiola, T., Alafuzoff, I., & Miettinen, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00593.x · Cited by 109 · cited 1×
“Findings of a deregulation of proteins involved in structural plasticity of axons and dendrites [1, 51, 77, 93, 116, 146] as well as results of computational studies [76, 85] indicate a failure of local neuronal regulatory mechanisms of synaptic plasticity and make a primary disturbance of synapse turnover very likely.”
ResultGärtner, U., Holzer, M., & Arendt, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00059-7 · Cited by 106 · cited 3×
“stages of AD prior to any noticeable pathological alterations, such as plaque or tangle formation [60, 61].”
BackgroundSelf-citationLeuba, G., Savioz, A., Vernay, A., Carnal, B., Kraftsik, R., Tardif, E., Riederer, I., & Riederer, B. M. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15112 · Cited by 103 · cited 1×
“Other studies indicated an increase in drebrin in the frontal cortex of patients with MCI followed by a 40% to 60% decrease in severe AD [36], an increase in the expression of postsynaptic density protein PSD-95 in AD brain [109], as well as an elevation in glutamatergic presynaptic bouton density in midfrontal gyrus…”
BackgroundWakabayashi, K., Honer, W. G., & Masliah, E. (1994) · Brain Research · doi:10.1016/0006-8993(94)91709-4 · Cited by 102 · cited 4×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
BackgroundResultInfluentialBrun, A. E., Liu, X., & Erikson, C. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0021 · Cited by 99 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Zampieri, N., Xu, C.-F., Neubert, T. A., & Chao, M. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412957200 · Cited by 99
Chromogranin peptides in Alzheimer's disease
Lechner, T., Adlassnig, C., Humpel, C., Kaufmann, W. A., Maier, H., Kramer-Reinstadler, K., Hinterhoelzl, J., Mahata, S. K., Jellinger, K. A., & Marksteiner, J. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.018 · Cited by 96 · cited 1×
“Chromogranin B, secretogranin II (chromogranin C), secretoneurin [95, 106, 107, 127]”
BackgroundShimohama, S., Kamiya, S., Taniguchi, T., Akagawa, K., & Kimura, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6940 · Cited by 95 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Davidsson, P., Jahn, R., Bergquist, J., Ekman, R., & Blennow, K. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815094 · Cited by 93 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
latheo, a Drosophila Gene Involved in Learning, Regulates Functional Synaptic Plasticity
Rohrbough, J. C., Pinto, S., Mihalek, R., Tully, T., & Broadie, K. S. (1999) · Neuron · doi:10.1016/s0896-6273(00)80753-9 · Cited by 93
Synaptic Pathology of Alzheimer's Diseasea
LASSMANN, H., FISCHER, P., & JELLINGER, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23028.x · Cited by 90 · cited 1×
“Synaptic pathology in AD is reflected by a loss of all major components of small synaptic vesicles that accommodate classical neurotransmitters and large dense core vesicles that store most peptides, together with a loss of molecular components of pre- and postsynaptic compartments accompanied by extensive pathologica…”
BackgroundWeiler, R., Lassmann, H., Fischer, P., Jellinger, K., & Winkler, H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81408-g · Cited by 89 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Gottfries, C.-G., Karlsson, I., & Svennerholm, L. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002736 · Cited by 85 · cited 1×
“This assumption is further supported by alterations in the composition [20, 67, 102, 126, 205] and fluidity of membranes [53, 238] as well as by direct morphological evidence of a disturbed axonal and dendritic remodeling (for review, see [4, 5]).”
ResultHu, N.-W., Smith, I. M., Walsh, D. M., & Rowan, M. J. (2008) · Brain · doi:10.1093/brain/awn174 · Cited by 84 · cited 1×
“Intracerebroventricular injections of soluble synthetic Ab140-dimers rapidly inhibit the plasticity of excitatory synaptic transmission at doses of 10-42 pmol comparable to natural Ab [87].”
BackgroundHärtig, W., Stieler, J., Boerema, A. S., Wolf, J., Schmidt, U., Weißfuß, J., Bullmann, T., Strijkstra, A. M., & Arendt, T. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05250.x · Cited by 82
Self-citationInduction of p21ras in Alzheimer pathology
Gärtner, U., Holzer, M., Heumann, R., & Arendt, T. (1995) · NeuroReport · doi:10.1097/00001756-199507100-00020 · Cited by 80
Self-citationGibson, P. H. (1983) · Acta Neuropathologica · doi:10.1007/bf00684929 · Cited by 79
Neuronal activity during sleep and complete bouts of hibernation
Krilowicz, B. L., Glotzbach, S. F., & Heller, H. C. (1988) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1988.255.6.r1008 · Cited by 77 · cited 1×
“Depression of the metabolic state of neurons during torpor in hibernating mammals leads to greatly reduced electroencephalographic activity [58, 103].”
BackgroundSynaptic Pathology in Prefrontal Cortex is Present Only with Severe Dementia in Alzheimer Disease
Minger, S. L., Honer, W. G., Esiri, M. M., McDonald, B., Keene, J., Nicoll, J. A. R., Carter, J., Hope, T., & Francis, P. T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.929 · Cited by 76 · cited 1×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
ResultMartin-Morris, L. E., & White, K. (1990) · Development · doi:10.1242/dev.110.1.185 · Cited by 75
In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice
Giacchino, J. L., Criado, J. R., Games, D., & Henriksen, S. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02615-9 · Cited by 73 · cited 2×
“Synaptotrophic function of human wild-type APP and its failure in FAD-mutated APP Disturbances of synaptic function and plasticity have also been observed in transgenic mice overexpressing FAD- mutated APP [32, 54, 62, 65].”
BackgroundFrontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
Hansen, L. A., Daniel, S. E., Wilcock, G. K., & Love, S. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.653 · Cited by 73 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Surprises from Drosophila: genetic mechanisms of synaptic development and plasticity
Featherstone, D. E., & Broadie, K. S. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00383-x · Cited by 72 · cited 1×
“Such a mechanism has indeed been identified in Drosophila, where Latheo might serve as an information shuttle between the nerve terminal and the nucleus participating in synapse-to-nucleus sigaling [52].”
BackgroundShigematsu, K., McGeer, P. L., & McGeer, E. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)91697-d · Cited by 70 · cited 2×
“APP undergoes fast axonal transport [101, 178, 229] and is targeted to synaptic sites [187, 193].”
BackgroundBrown, D. F., Risser, R. C., Bigio, E. H., Tripp, P., Stiegler, A., Welch, E., Eagan, K. P., Hladik, C. L., & White, C. L. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199810000-00007 · Cited by 69 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Rapoport, S. I. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014174 · Cited by 69 · cited 1×
“Similarly, synaptic degeneration might be a slow process progressing from an initially reversible functionally responsive stage of down-regulation of synaptic function to stages irreversibly associated by marked synapse loss [169].”
BackgroundSalbaum, J. M., & Ruddle, F. H. (1994) · Journal of Experimental Zoology · doi:10.1002/jez.1402690205 · Cited by 68 · cited 1×
“After development is completed, high expression levels of APP persist in the adult olfactory bulb, where continuous synaptogenesis occurs in the adult animal [114, 179], and its expression level increases in animals reared in enriched environments [89].”
BackgroundPerdahl, E., Adolfsson, R., Alafuzoff, I. I., Albert, K. A., Nestler, E. J., Greengard, P., & Winblad, B. G. (1984) · Journal of Neural Transmission · doi:10.1007/bf01245030 · Cited by 67 · cited 2×
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Synaptic Proteins in Alzheimer's Disease
Marksteiner, J., Kaufman, W. A., Gurka, P., & Humpel, C. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:53 · Cited by 66 · cited 1×
“Chromogranin B, secretogranin II (chromogranin C), secretoneurin [95, 106, 107, 127]”
BackgroundHeffernan, J. M., Eastwood, S. L., Nagy, Z., Sanders, M. W., McDonald, B., & Harrison, P. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6772 · Cited by 65 · cited 5×
“severity of cognitive impairment and synaptic pathology in AD agree on the correlation between lower synaptic protein levels and some aspect of cognitive dysfunction [22, 79, 106, 131, 132, 133, 149, 180, 181, 206, 207, 211, 221], although in several studies, correlations between synaptic proteins and cognitive functi…”
BackgroundResultInfluentialNeuronal activation of Ras regulates synaptic connectivity
Arendt, T., Gärtner, U., Seeger, G., Barmashenko, G., Palm, K., Mittmann, T., Yan, L., Hümmeke, M., Behrbohm, J., Brückner, M. K., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03409.x · Cited by 65 · cited 1×
“The p21ras-MAP-kinase pathway, a mitogenic pathway that in cycling cells controls proliferation, in the adult nervous system regulates neuronal plasticity of differentiated neurons [9].”
BackgroundSelf-citationSynaptic β-amyloid precursor proteins increase with learning capacity in rats
Huber, G., Bailly, Y. J. R., Martin, J. R., Mariani, J., & Brugg, B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00120-6 · Cited by 65 · cited 1×
“After development is completed, high expression levels of APP persist in the adult olfactory bulb, where continuous synaptogenesis occurs in the adult animal [114, 179], and its expression level increases in animals reared in enriched environments [89].”
BackgroundCHANG, J. W., SCHUMACHER, E., COULTER, P. M., VINTERS, H. V., & WATSON, J. B. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00004 · Cited by 64 · cited 1×
“Neurogranin, drebrin E and A [31, 38, 75, 77] Acta Neuropathol (2009) 118:167–179 169”
BackgroundThe origin recognition core complex regulates dendrite and spine development in postmitotic neurons
Huang, Z., Zang, K., & Reichardt, L. F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505075 · Cited by 63 · cited 1×
“Latheo is a homologue of ORC3, a component of the origin recognition complex (ORC), a critical ‘‘guard’’ of DNA replication that controls initiation of DNA replication and prevents re-replication during the cell cycle [88].”
BackgroundProgressive Reduction of Synaptophysin Message in Single Neurons in Alzheimer Disease
Callahan, L. M., Vaules, W. A., & Coleman, P. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.384 · Cited by 61 · cited 1×
“between synaptophysin mRNA and tangle formation at the level of individual neurons directly proved a significant reduction of synaptophysin mRNA in neurons affected by tangle formation [29, 30].”
BackgroundLinking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity
Arendt, T., & Brückner, M. K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.005 · Cited by 61 · cited 1×
“More recently, we could provide evidence for an involvement of ORC units in AD pathology [8].”
BackgroundSelf-citationAnatomie du système nerveux de l'homme
Gehuchten, A. V. (1906) · Medical Entomology and Zoology · Cited by 60
Differential Expression of Rat Brain Synaptic Proteins in Development and Aging
Shimohama, S., Fujimoto, S., Sumida, Y., Akagawa, K., Shirao, T., Matsuoka, Y., & Taniguchi, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9480 · Cited by 59 · cited 2×
“Synaptic pathology in AD is reflected by a loss of all major components of small synaptic vesicles that accommodate classical neurotransmitters and large dense core vesicles that store most peptides, together with a loss of molecular components of pre- and postsynaptic compartments accompanied by extensive pathologica…”
BackgroundRoßner, S., Ueberham, U., Schliebs, R., Perez-Polo, J. R., & Bigl, V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020757.x · Cited by 55
Kirazov, E., Kirazov, L., Bigl, V., & Schliebs, R. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00012-0 · Cited by 55 · cited 1×
“Within the brain, APP can be detected in synaptic membranes [97] and has been shown to localize to postsynaptic densities, axons and dendrites [187, 193].”
BackgroundNeuronal-Based Synaptic Compensation: A Computational Study in Alzheimer's Disease
Horn, D., Levy, N., & Ruppin, E. (1996) · Neural Computation · doi:10.1162/neco.1996.8.6.1227 · Cited by 54 · cited 1×
“Findings of a deregulation of proteins involved in structural plasticity of axons and dendrites [1, 51, 77, 93, 116, 146] as well as results of computational studies [76, 85] indicate a failure of local neuronal regulatory mechanisms of synaptic plasticity and make a primary disturbance of synapse turnover very likely.”
ResultAlzheimer pathology of patients carrying apoliprotein E ε4 allele
Heinonen, O. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00076-q · Cited by 52
Kaufmann, W. A., Barnas, U., Humpel, C., Nowakowski, K., DeCol, C., Gurka, P., Ransmayr, G., Hinterhuber, H., Winkler, H., & Marksteiner, J. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00121.x · Cited by 52 · cited 1×
“Chromogranin B, secretogranin II (chromogranin C), secretoneurin [95, 106, 107, 127]”
BackgroundMajocha, R. E., Jungalwala, F. B., Rodenrys, A., & Marotta, C. A. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11798.x · Cited by 52 · cited 1×
“This assumption is further supported by alterations in the composition [20, 67, 102, 126, 205] and fluidity of membranes [53, 238] as well as by direct morphological evidence of a disturbed axonal and dendritic remodeling (for review, see [4, 5]).”
ResultExpression of cell cycle‐related proteins in developing and adult mouse hippocampus
Schmetsdorf, S., Gärtner, U., & Arendt, T. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.019 · Cited by 49 · cited 1×
“they might serve in alternative ‘‘non-canonical functions’’ such as regulation of neuronal and synaptic plasticity [185, 186].”
BackgroundSelf-citation
Research works printed but not linked: 11
- Brunelli MP, Kowall NW, Lee JM, McKee AC (1991) Synaptophysin immunoreactivity is depleted in cortical laminae with dense dystrophic neurites and neurofibrillary tangles. J Neuropathol Exp Neurol 50:315
- Duval M (1895) Hypothèses sur la physiologie des centres nerveux; théorie histologique du sommeil. Comptes Rendus Hebdomadaires des Séances et Mémoires de la Société de Biologie 47:74–77
- Duval M (1900) Les neurones. L’amiboïsme nerveux la théorie histologique du sommeil. Revue de l’Ècole d’Anthropologie de Paris 10:37–71
- Hut RA, de Wilde MC, Strijkstra AM, Van der Zee EA, Daan S (2001) Neuronal changes in the hippocampus and SCN of hibernating ground squirrels. Soc Neurosci Abstr 27:535.11
- Lépine MR (1895) Théorie mécanique de la paralysie hystérique, du somnambulisme, du sommeil naturel et de la distraction. Soc Biol 5:85–86
- Lugaro E (1895) Sulle Modificazioni delle cellule nervose. Lo Sperimentale 49:159–193
- Lugaro E (1899) I recenti progressi dell’anatomia del sistema nervoso in rapporto alla psicologia ed alla psichiatria. Rivista di Patologia Nervosa e Mentale 4:481–514
- Lugaro E (1900) I recenti progressi dell’anatomia del sistema nervoso in rapporto alla psicologia ed alla psichiatria. Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali 26:831–894
- Masliah E, Terry R (1994) The role of synaptic pathology in the mechanisms of dementia in Alzheimer’s disease. Clin Neurosci 1:192–198
- Ramón y Cajal S (1911) Histologie du systeme nerveux. A. Maloine. Paris. (This is the second edition, in French, of the Textura del sistema nervioso del hombre y los vertebrados of 1899. Quotations here are from the English translation by N. and L. Swanson, vol 1. Oxford University Press 1995, New York
- Tanzi E (1893) I fatti e le induzioni nell’odierna istologia del sistema nervoso. Rivista Sperimentale di Frenetria e Medicina Legale della Alienzioni mentali 19:419–472
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
“Detailed analysis of postmortem tissue has revealed synapse loss in mild cognitive impairment (MCI), but an even greater loss in Alzheimer's disease, indicating that synapse loss occurs early in the progression of Alzheimer's disease and worsens as the disease advance”
BackgroundOxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 843
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768
Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 519
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572
“2709" language="eng" relation="no"> Episodic hippocampal-dependent memory loss, the earliest clinical sign of Alzheimer's disease, is thought to be a result of changes in synaptic function rather than neuronal los”
Background
Metadata
- Authors
- Arendt, T.
- Affiliations
- Leipzig University (DE)
- Corresponding author
- Arendt, Thomas
- ORCID
- Arendt, Thomas
- Venue
- Acta Neuropathologica
- Published
- 2009-04-24
- Volume
- 118
- Issue
- 1
- Pages
- 167-179
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2147435466
- Cited by
- 517
- References
- 233
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 21 · 2023: 28 · 2022: 39 · 2021: 47 · 2020: 32 · 2019: 28 · 2018: 31 · 2017: 28 · 2016: 35 · 2015: 19 · 2014: 32 · 2013: 44 · 2012: 29
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- synaptic degeneration, Alzheimer's disease, synaptic loss, mild cognitive impairment, cognitive impairment, synaptic plasticity, amyloid precursor protein, amyloid-beta oligomers, neuronal cell death
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cell Cycle, Cognition Disorders, Humans, Nerve Degeneration, Neuronal Plasticity, Neurons, Phosphorylation, Receptors, Cell Surface, Synapses, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Protease Nexins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.